BioSig Technologies (NASDAQ:BSGM) versus Heyu Biological Technology (OTCMKTS:HYBT) Critical Comparison

Heyu Biological Technology (OTCMKTS:HYBT) and BioSig Technologies (NASDAQ:BSGM) are both small-cap computer and technology companies, but which is the better investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, dividends, valuation, profitability, earnings and institutional ownership.

Volatility and Risk

Heyu Biological Technology has a beta of -17.74, meaning that its stock price is 1,874% less volatile than the S&P 500. Comparatively, BioSig Technologies has a beta of 0.65, meaning that its stock price is 35% less volatile than the S&P 500.

Analyst Recommendations

This is a summary of recent ratings for Heyu Biological Technology and BioSig Technologies, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Heyu Biological Technology	0	0	0	0	N/A
BioSig Technologies	0	0	0	0	N/A

Profitability

This table compares Heyu Biological Technology and BioSig Technologies’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Heyu Biological Technology	-453.55%	-6.43%	-4.43%
BioSig Technologies	-44,832.50%	N/A	-746.77%

Institutional & Insider Ownership

7.2% of BioSig Technologies shares are held by institutional investors. 89.2% of Heyu Biological Technology shares are held by insiders. Comparatively, 9.3% of BioSig Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Valuation and Earnings

This table compares Heyu Biological Technology and BioSig Technologies’ top-line revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Heyu Biological Technology	$80,000.00	322.65	-$270,000.00	N/A	N/A
BioSig Technologies	$27,000.00	236.22	-$29.04 million	N/A	N/A

Heyu Biological Technology has higher revenue and earnings than BioSig Technologies.

Summary

Heyu Biological Technology beats BioSig Technologies on 6 of the 9 factors compared between the two stocks.

About Heyu Biological Technology

Hong Chang Biotechnologies (HK) Limited was incorporated in 2023 and is based in Kowloon, Hong Kong. Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Zengqiang Investment Limited. As of September 4, 2023, Hong Chang Biotechnologies (HK) Limited operates as a subsidiary of Heyu Biological Technology Corporation.

About BioSig Technologies

BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.